KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Income from Continuing Operations (2016 - 2025)

Idexx Laboratories has reported Income from Continuing Operations over the past 17 years, most recently at 248188000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 248188000.0 for Q4 2025, up 14.82% from a year ago — trailing twelve months through Dec 2025 was 1059464000.0 (up 19.33% YoY), and the annual figure for FY2025 was 1059464000.0, up 19.33%.
  • Income from Continuing Operations for Q4 2025 was 248188000.0 at Idexx Laboratories, down from 274610000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for IDXX hit a ceiling of 293989000.0 in Q2 2025 and a floor of 131979000.0 in Q2 2022.
  • Median Income from Continuing Operations over the past 5 years was 208260000.0 (2021), compared with a mean of 210815300.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 82.64% in 2021 and later plummeted 34.86% in 2022.
  • Idexx Laboratories' Income from Continuing Operations stood at 162771000.0 in 2021, then rose by 5.8% to 172207000.0 in 2022, then grew by 12.96% to 194521000.0 in 2023, then rose by 11.12% to 216149000.0 in 2024, then grew by 14.82% to 248188000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 248188000.0 (Q4 2025), 274610000.0 (Q3 2025), and 293989000.0 (Q2 2025) per Business Quant data.